Edge Therapeutics Inc Stock Nasdaq
Equities
US2798701098
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 275K | Capitalization | 120M |
---|---|---|---|---|---|
Net income 2024 * | -51M | Net income 2025 * | -63M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 436 x |
P/E ratio 2024 * |
-2.2
x | P/E ratio 2025 * |
-2.03
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.33% |
Latest transcript on Edge Therapeutics Inc
Managers | Title | Age | Since |
---|---|---|---|
Frank Bedu-Addo
FOU | Founder | 59 | 19-03-14 |
Director of Finance/CFO | 55 | Dec. 03 | |
David Schaaf
CTO | Chief Tech/Sci/R&D Officer | - | 22-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Glover
CHM | Chairman | 65 | 19-04-01 |
Otis Brawley
BRD | Director/Board Member | 64 | 20-11-02 |
Richard Sykes
BRD | Director/Board Member | 79 | 19-02-28 |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+0.55% | 22.15B | |
-17.37% | 21.02B | |
-8.65% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |